Status:

COMPLETED

Influenza Vaccine in Pediatric Transplant Subjects

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Influenza

Eligibility:

All Genders

6-17 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate how well children responds to the recommended trivalent subviron influenza vaccine (flu shot). Children who have had a liver transplant and receive their post-...

Detailed Description

The purpose of this study is to investigate the humoral and cell-mediated immune response to the trivalent subviron influenza vaccine in pediatric liver transplant recipients. Additionally, researcher...

Eligibility Criteria

Inclusion

  • Informed consent from parent/guardian and assent from participants, when applicable, must have been obtained and signed freely.
  • Between the ages of 6 months and 17 years.
  • Three months have elapsed since liver transplantation.
  • Recipient of a liver transplant or live with a sibling who is the recipient of a liver transplant.
  • Must have the ability to comply with the study procedures for the entire length of the study.

Exclusion

  • Previous immunization with an influenza vaccine for the 2004-2005 or 2005-2006 influenza season.
  • Known hypersensitivity reaction to the vaccine or vaccine component including eggs or gelatin.
  • History of Guillian-Barré syndrome.
  • Receipt of an immunoglobulin product (including intravenous or intramuscular immunoglobulin preparations, cytomegalovirus hyperimmunoglobulin and varicella-zoster immunoglobulin) within 3 months of vaccination.
  • Receipt of any live viral vaccines within 4 weeks or an inactivated viral vaccine within 2 weeks of enrollment.
  • Subjects who have experienced an acute febrile illness within the preceding 48 hours will have immunization deferred and be rescheduled once their fever has resolved.

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

End Date :

September 1 2006

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00133510

Start Date

November 1 2004

End Date

September 1 2006

Last Update

August 27 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mount Sinai Hospital

New York, New York, United States, 10029